TRML: Tourmaline Bio, Inc. Stock

by  •  • Comments Off on TRML: Tourmaline Bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 405.98
Enterprise Value ($M) 265.26
Book Value ($M) 205.04
Book Value / Share 7.99
Price / Book 1.98
NCAV ($M) 203.62
NCAV / Share 7.94
Price / NCAV 1.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -7.02
Return on Equity (ROE) -148.32

Liquidity (mrq)
Quick Ratio 41.76
Current Ratio 41.76

Balance Sheet (mrq) ($M)
Current Assets 208.87
Assets 210.29
Liabilities 5.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -45.41
Net Income -42.12

Cash Flow Statement (mra) ($M)
Cash From Operations -28.08
Cash from Investing 3.84
Cash from Financing 156.72

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-15 13G/A Pfizer Inc 4.96
02-14 13G/A Hydra LLC 6.60 41.59
02-14 13G Blue Owl Capital Holdings LP 6.55
02-14 13G/A Citadel Advisors Llc 0.00
02-14 13G/A Ra Capital Management, L.p. 0.00
02-09 13G/A Blackstone Holdings II L.P. 0.00
02-09 13G TCG Crossover GP I, LLC 5.90
02-07 13G/A BML Investment Partners, L.P. 1.00
10-30 13D/A Qiming U.S. Healthcare GP II, LLC 3.20
10-27 13G Deep Track Capital, LP 8.93

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION R

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 37,778 441,833 8.55
2024-05-01 39,707 291,234 13.63
2024-04-30 71,916 221,089 32.53
2024-04-29 59,464 70,005 84.94

(click for more detail)

Similar Companies
TERN – Terns Pharmaceuticals, Inc. TLRY – Tilray Brands, Inc.
TNYA – Tenaya Therapeutics, Inc. TSHA – Taysha Gene Therapies, Inc.
TSVT – 2seventy bio, Inc.


Financial data and stock pages provided by
Fintel.io